Medicine
Tri-luma 0.1 mg/40 mg/0.5 mg per g cream
Tri-luma 0.1 mg/40 mg/0.5 mg per g cream is a prescription medicine containing Fluocinolone acetonide, Hydroquinone and Tretinoin for topical use, marketed by Galderma Laboratories, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store in a refrigerator, 2° - 8°C (36° - 46°F). Protect from freezing.
Key facts
- Active ingredient (INN)
- Fluocinolone acetonide, Hydroquinone and Tretinoin
- Brand
- Tri-luma
- Strength
- 0.1 mg/40 mg/0.5 mg per g
- Dosage form
- Cream
- Route
- Topical
- Packs
- 1 tube
- Marketing authorisation holder
- Galderma Laboratories
- Manufacturer
- Galderma Laboratories
- Origin register
- US FDA, United States
- Storage
- Store in a refrigerator, 2° - 8°C (36° - 46°F). Protect from freezing.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.32Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 January 2002
- Identifiers
- RxCUI 1191262, 1191264DailyMed set ID a35fa709-5eb5-4429-b38f-f1e0019bf0eeNDC 0299-5950Application NDA021112
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 tube in 1 carton / 30 g in 1 tube | 0299-5950-30 | Galderma Laboratories | 18 January 2007 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 18 January 2002 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Fluocinolone acetonide, Hydroquinone and Tretinoin is a fixed-dose combination of a corticosteroid, a melanin synthesis inhibitor and a retinoid. It is available as cream for topical use. MedsAcross supplies Fluocinolone acetonide, Hydroquinone and Tretinoin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Fluocinolone acetonide, Hydroquinone and TretinoinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- TRI-LUMA prescribing information (Galderma Laboratories) · U.S. National Library of Medicine, DailyMed
Need Tri-luma 0.1 mg/40 mg/0.5 mg per g cream for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.